Bank Of New York Mellon Corp Bei Gene, Ltd. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$215.53 - $274.5 $1.46 Million - $1.86 Million	6,783 New	6,783 $1.46 Billion
Q4 2022 Feb 14, 2023	BUY	$125.51 - $229.3 $899,906 - $1.64 Million	7,170 New	7,170 $1.58 Million
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $177,666 - $272,619	1,348 Added 2.39%	57,839 $7.8 Million
Q2 2022 Aug 15, 2022	BUY	$121.11 - $216.05 $156,474 - $279,136	1,292 Added 2.34%	56,491 $9.14 Million
Q1 2022 May 11, 2022	BUY	$146.52 - $269.56 $45,128 - $83,024	308 Added 0.56%	55,199 $10.4 Million
Q4 2021 Feb 11, 2022	SELL	$248.56 - $389.34 $994 - $1,557	-4 Reduced 0.01%	54,891 $14.9 Million
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $1.34 Million - $2.17 Million	5,387 Added 10.88%	54,895 $19.9 Million
Q2 2021 Aug 11, 2021	SELL	$292.75 - $367.01 $2.21 Million - $2.77 Million	-7,548 Reduced 13.23%	49,508 $17 Million
Q1 2021 May 13, 2021	SELL	$260.64 - $382.12 $236,400 - $346,582	-907 Reduced 1.56%	57,056 $19.9 Million
Q4 2020 Feb 09, 2021	SELL	$221.31 - $316.61 $4.26 Million - $6.09 Million	-19,237 Reduced 24.92%	57,963 $15 Million
Q3 2020 Nov 12, 2020	BUY	$189.18 - $286.44 $277,337 - $419,921	1,466 Added 1.94%	77,200 $22.1 Million
Q2 2020 Aug 12, 2020	BUY	$123.9 - $195.41 $1.08 Million - $1.7 Million	8,708 Added 12.99%	75,734 $14.3 Million
Q1 2020 May 06, 2020	BUY	$121.84 - $173.19 $319,586 - $454,277	2,623 Added 4.07%	67,026 $8.25 Million
Q4 2019 Feb 14, 2020	SELL	$115.78 - $208.34 $260,505 - $468,765	-2,250 Reduced 3.38%	64,403 $10.7 Million
Q3 2019 Nov 07, 2019	BUY	$120.61 - $148.29 $211,188 - $259,655	1,751 Added 2.7%	66,653 $8.16 Million
Q2 2019 Aug 12, 2019	BUY	$113.99 - $146.86 $486,851 - $627,239	4,271 Added 7.04%	64,902 $8.05 Million
Q1 2019 May 14, 2019	BUY	$122.82 - $151.83 $230,041 - $284,377	1,873 Added 3.19%	60,631 $8 Million
Q4 2018 Feb 11, 2019	BUY	$107.01 - $175.15 $6.29 Million - $10.3 Million	58,758 New	58,758 $8.24 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.03 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.24 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$995 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$956 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$712 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account